ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 211.00
-8.50 (-3.87%)
Aug 5, 2026, 2:04 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 14.96 billion as of August 5, 2026. Its market cap has increased by 165.84% in one year.
Market Cap
14.96B
Enterprise Value
13.99B
Revenue
38.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
211.00
ChartMarket Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 14.96B, an increase of 1,409.75%. That is a compound annual growth rate of 71.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 14.96B | 270.16% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiMed Biologics | 15.55B |
| Medigen Vaccine Biologics | 15.40B |
| Ever Supreme Bio Technology | 14.91B |
| Lumosa Therapeutics | 14.57B |
| EirGenix | 13.96B |
| Tanvex BioPharma | 10.07B |
| Gongwin Biopharm Holdings | 9.68B |
| Polaris Group | 9.63B |